Clinical Trial Update: Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on urate lowering therapies and their potential effects on left ventricular diastolic dysfunction in patients with hyperuricemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia
• Left Ventricular Diastolic Dysfunction
• Metabolic Syndrome

Snippet

Sponsor: National Defense Medical Center, Taiwan | Conditions: Hyperuricemia, Metabolic Syndrome | Phase 4 | Status: UNKNOWN